422 related articles for article (PubMed ID: 27896591)
1. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer.
Timur SS; Bhattarai P; Gürsoy RN; Vural İ; Khaw BA
Pharm Res; 2017 Feb; 34(2):352-364. PubMed ID: 27896591
[TBL] [Abstract][Full Text] [Related]
2. Bispecific antibody complex pre-targeting and targeted delivery of polymer drug conjugates for imaging and therapy in dual human mammary cancer xenografts: targeted polymer drug conjugates for cancer diagnosis and therapy.
Khaw BA; Gada KS; Patil V; Panwar R; Mandapati S; Hatefi A; Majewski S; Weisenberger A
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1603-16. PubMed ID: 24643779
[TBL] [Abstract][Full Text] [Related]
3. Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.
Patil V; Gada K; Panwar R; Varvarigou A; Majewski S; Weisenberger A; Ferris C; Tekabe Y; Khaw BA
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):824-39. PubMed ID: 22302089
[TBL] [Abstract][Full Text] [Related]
4. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
Patil V; Gada K; Panwar R; Majewski S; Tekabe Y; Varvarigou A; Khaw BA
J Drug Target; 2013 Dec; 21(10):1012-21. PubMed ID: 23863118
[TBL] [Abstract][Full Text] [Related]
5. Bispecific antibody complex pre-targeted delivery of polymer-drug conjugates for cancer therapy.
Gada KS; Patil V; Panwar R; Hatefi A; Khaw BA
Drug Deliv Transl Res; 2012 Feb; 2(1):65-76. PubMed ID: 25786600
[TBL] [Abstract][Full Text] [Related]
6. Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers.
Panwar R; Bhattarai P; Patil V; Gada K; Majewski S; Khaw BA
J Nucl Cardiol; 2019 Aug; 26(4):1327-1344. PubMed ID: 29392624
[TBL] [Abstract][Full Text] [Related]
7. An in vitro demonstration of overcoming drug resistance in SKOV3 TR and MCF7 ADR with targeted delivery of polymer pro-drug conjugates.
Bhattarai P; Vance D; Hatefi A; Khaw BA
J Drug Target; 2017 Jun; 25(5):436-450. PubMed ID: 27937085
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer.
Timur SS; Yöyen-Ermiş D; Esendağlı G; Yonat S; Horzum U; Esendağlı G; Gürsoy RN
Eur J Pharm Biopharm; 2019 Mar; 136():138-146. PubMed ID: 30660694
[TBL] [Abstract][Full Text] [Related]
9. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
10. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.
Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W
J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801
[TBL] [Abstract][Full Text] [Related]
11. Multistage Continuous Targeting with Quantitatively Controlled Peptides on Chitosan-Lipid Nanoparticles with Multicore-Shell Nanoarchitecture for Enhanced Orally Administrated Anticancer In Vitro and In Vivo.
Su CW; Yen CS; Chiang CS; Hsu CH; Chen SY
Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27634372
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
13. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
[TBL] [Abstract][Full Text] [Related]
14. LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.
Wang Z; Yu Y; Ma J; Zhang H; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Mol Pharm; 2012 Sep; 9(9):2646-57. PubMed ID: 22853186
[TBL] [Abstract][Full Text] [Related]
15. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers.
Liang Y; Li S; Wang X; Zhang Y; Sun Y; Wang Y; Wang X; He B; Dai W; Zhang H; Wang X; Zhang Q
J Control Release; 2018 Apr; 275():129-141. PubMed ID: 29408580
[TBL] [Abstract][Full Text] [Related]
17. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
18. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
19. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
